Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ImpactRx | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

ImpactRx

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ImpactRx, Inc. has named Richard C. Altus president and chief executive officer. Mr. Altus served as president and acting chief executive officer since May of this year. Per Lofberg, chairman of ImpactRx’s board of directors and president of Merck Capital Ventures, an investor in ImpactRx, stated, “During his first six months on the job, Rich has proven to be an effective leader and has continued to build on the company’s successes. He has established a clear strategic direction for the company and has made real progress in ensuring that the organization executes its business objectives. This action by the board to fully endorse him as president and chief executive officer is confirmation of our confidence in Rich’s ability to lead ImpactRx into the future.”

Mr. Altus, who joined the company in 2002, has more than 25 years of financial and management experience in both private and public companies. Prior to his current position, he was the company’s chief financial officer. Before joining the company, he served as chief operating officer for Medical Broadcasting Company, a company that was an innovator in the use of online and e-marketing techniques for the pharmaceutical and biotechnology industries.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters